Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 500 mg Tablets Under Fed Conditions.

NCT07633054 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence Study in Healthy Subjects

Interventions

DRUG: Synjardy 5/850 mg tablet, Reference
DRUG: Empagliflozin/metformin 12.5/500 mg test

Sponsor

ADIUM